Bio Protocol vs PIVX — how do they compare? Bio Protocol trades at Rp517 (market cap Rp1,15T, Rp264,79M 24h volume), while PIVX trades at Rp671.08 (market cap Rp72,86M, Rp45,95M 24h volume). The key difference: Bio Protocol is far larger — about 15783.7× PIVX's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while PIVX's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and PIVX for 8 Days on average.
| BIO | PIVX | |
|---|---|---|
Market Cap | Rp1,15T | Rp72,86M |
Volume (24h) | Rp264,79M | Rp45,95M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 104,9M PIVX |
Typical Hold Time | 16 Days | 8 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
PIVX trades at Rp665.62 with a market cap of Rp72.86M, showing a bearish technical signal overall despite bullish oscillators. The current price sits near support at Rp657, with key resistance at Rp687. No major protocol updates or ecosystem developments are noted recently. Trading volume and network activity appear subdued, with an average hold time of 8 days indicating short-term trading interest.
Outlook remains cautious due to bearish momentum and limited fundamental catalysts. Opportunities include potential rebounds from support levels, but risks involve low liquidity and high volatility. Investors should monitor for any protocol upgrades or exchange listings that could drive momentum.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →PIVX, launched in 2016, is a decentralized, open-source blockchain project governed by a community-driven DAO. It uses advanced cryptography to prioritize user financial data protection.
Read more on PIVX →